This article relies largely or entirely on a single source. (April 2015) |
4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.
Names | |
---|---|
Preferred IUPAC name
2-(3,5-Dimethoxy-4-methylphenyl)ethan-1-amine | |
Other names
3,5-Dimethoxy-4-methylphenethylamine
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C11H17NO2 | |
Molar mass | 195.26 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Effects
editThe effects of DESOXY vary significantly from mescaline, despite their chemical similarity.[citation needed]
Dosage
editA typical dosage is within the range of 40–120 mg and lasts 6–8 hours.[1]
Legality
editIn 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.
DESOXY is also an isomer of 2C-D which makes it a schedule 1 drug in the United States.
References
edit- ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
External links
edit- Alexander Shulgin, Jacob, P. Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs. NIDA Research Monograph 146 (Hallucinogens: An Update), 1994.